Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

Tolerance study of allogeneic of Adipose tissue derived mesenchymal Stroma/stem Cells (AdMSC) transplantation in patients with critical limb… Recruiting

2023-509312-29-00 critical limb ischemia 1 2026-02-11
Modulation of the Extent of Ischemic Brain Damage by Protecting the Endothelial Glycocalyx with Low-Dose Albumin Administration (MOZEG) Recruiting

2023-509261-20-00 Ischemic stroke 4 2026-02-09
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
APAC (antiplatelet, anticoagulant) antithrombotic treatment for limb-threatening impairment of blood flow (HEALING-study) Recruiting

2025-522390-11-00 Peripheral arterial occlusive disease (PAOD) 4 2026-01-29
A randomized, double-blind, placebo-controlled, multicentre trial, assessing the impact of ferric carboxymaltose on exercise capacity and fu… Recruiting

2025-522936-14-00 Pulmonary hypertension 6 2026-01-27
The Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation Recruiting

2025-523391-22-01 Atrial fibrillation 6 2026-01-20
LA-HCM : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients with Abnormal Left Atrial Strain : A Randomized M… Recruiting

2024-511084-28-00 Hypertrophic Cardiomyopathie 11 2026-01-12
A study to learn more about how well finerenone works, how safe it is, and how it moves into, through, and out of the body compared to place… Recruiting

2024-519829-38-00 Heart failure due to systemic left ventricular systolic 5 2026-01-09
HYDrochlorothiazidE compared to valsartan to treat arterial hypertension in patients with Hypertrophic obstructive CardioMyopathy – the HYDE… Recruiting

2024-520086-31-00 Hypertrophic cardiomyopathy 6 2026-01-07
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting

2025-520518-79-00 Atrial Fibrillation 4 2026-01-06
Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients. Recruiting

2025-521362-10-00 Frail older patients with atrial fibrillation or venous 11 2026-01-06
ANACOMP. A RANDOMIZED PHASE III MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF ANAKINRA VERSUS INTRAVENOUS IMMUNOGLOBULIN (IVIG) RET… Recruiting

2024-516244-25-00 Kawasaki disease 5 2026-01-06
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489 Recruiting

2025-521155-23-00 Pulmonary Arterial Hypertension 4 2025-12-19
A Phase 2a Trial to Investigate Safety, Tolerability and Exploratory Efficacy of AGP100 in Patients with Catecholaminergic Polymorphic Ventr… Recruiting

2025-521611-39-00 Catecholaminergic Polymorphic Ventricular Tachycardia 4 2025-12-18
A first-in-human study to learn about how safe BAY 3620122 is, how much of it gets absorbed in the blood, and how it affects the body of hea… Recruiting

2025-523301-15-00 Vasodilatory shock 1 2025-12-17
Evaluation of the effect of intravenous lidocaine on the systemic inflammatory response associated with cardiopulmonary bypass in patients u… Recruiting

2025-523534-11-00 Patients undergoing elective cardiac valve surgery and/ 4 2025-12-15
Heart rate control: Betablockers or Ivabradine therapy before cardiac computed tomography Recruiting

2025-522741-21-00 ischemic heart disease 6 2025-12-09
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non… Recruiting

2024-515125-28-00 Non-obstructive hypertrophic cardiomyopathy 4 2025-12-08
Proof-of-concept study of Empagliflozin in patients with pulmonary arterial hypertension (EmPAH) Recruiting

2024-517009-99-00 Pulmonary arterial hypertension 4 2025-12-03
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATI… Recruiting

2023-508874-27-00 Heart condition 5 2025-12-02
Dapagliflozine for cardio-renal protection at ICU discharge Recruiting

2024-510941-32-00 Adult patients discharged alive from ICU with a decreas 5 2025-12-02
Effects of continued administration of empagliflozin in patients with heart failure on active SGLT2 inhibitor treatment admitted for acute d… Recruiting

2024-517977-26-00 acute decompensated heart failure 5 2025-11-25
Optimal antiplatelet therapy in patients after coronary artery bypass grafting. Recruiting

2025-521892-30-00 Primary isolated CABG patients with stable coronary art 5 2025-11-24
The headache-inducing effects of cilostazol in men and women with migraine without aura Recruiting

2025-521520-29-00 Migraine 9 2025-11-21